Divis Laboratories Ltd share price logo

Divis Laboratories Ltd

NSE: DIVISLAB

BSE: 532488

Large Cap

Pharma Sector

₹10037.50

-26.50

(-0.26%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

What are INDmoney investors doing with Divis Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-7%

Searches for Divis Laboratories on INDmoney have decreased by 7% over the last 30 days.

Investment activity on INDmoney

+4.19%

Investment activity in Divis Laboratories among INDmoney users has increased by 4.19% over the last 30 days.

Among the most traded stocks

43rd

Divis Laboratories was the 43rd most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

21 days

INDmoney investors hold Divis Laboratories shares for an average of 21 days.

Key Events for Divis Laboratories

Upcoming Events

Next Results Date
07/11/2026

Last Dividend Declared

₹30.00 per share, declared on 23/05/2026

View Dividend History

Divis Laboratories Stock Performance

as on November 4, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹9,946.00
    ₹10,067.00
    downward going graph

    0.91%

    Downside

    0.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹5,647.50
    ₹10,067.00
    downward going graph

    43.74%

    Downside

    0.29%

    Upside

    downward going graph

Divis Laboratories share price movements today

Previous Close
₹10,064.00
Open
₹10,060.00
Volume
5.35L
Upper Circuit
₹10,327.50
Lower Circuit
₹9,726.50
Day's Low - High
₹9,946.00 - ₹10,067.00
52 Week Low - High
₹5,647.50 - ₹10,067.00

Divis Laboratories Historical Returns

1 Month Return
+ 9.44 %
3 Month Return
+ 20.12 %
1 Year Return
+ 47.9 %
3 Year Return
+ 186.99 %
5 Year Return
+ 93.24 %

Divis Laboratories Fundamentals

as on November 4, 2026 at 4:01 pm IST

Market Cap

₹2,67,167.58 Cr

Return on Equity (ROE)

16.5

PE Ratio (TTM)

91.32

Return on capital employed (ROCE)

21.38

Industry PE ratio

52.04

Beta (LTM)

0.62

P/B Ratio

9.43

Dividend Yield

0.5

PEG Ratio

3.9

Quarterly Earnings Growth YOY

65.5

EPS (TTM)

96.91

Book Value

632.49

Divis Laboratories Stock Valuation

as on November 4, 2026 at 4:01 pm IST

Divis Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (52.04x)

November 3, 2026

Today (91.32x)

November 3, 2026

Highest (91.32x)

November 3, 2026

LowHigh

Today’s Price to Earnings Ratio: 91.32x

Divis Laboratories Technical Analysis

Track how Divis Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish2
Bullish11
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
4.15
Bearish
CCI (20)
29.19
Neutral
RSI (14)
60.58
Neutral
Momentum (10)
-2.5
Bearish
ADI (14)
41.62
Bullish
Ultimate Oscillator (7,14,28)
94.18
Bullish

Moving Averages

Name

Value

Action

SMA (20)
10032.05
Bullish
EMA (20)
10031.49
Bullish
VWMA (20)
10033.68
Bullish
SMA (50)
10022.54
Bullish
EMA (50)
10023.13
Bullish
SMA (200)
10010.93
Bullish
EMA (200)
10010.9
Bullish
KAMA (200)
10021.09
Bullish
DEMA (200)
10021.03
Bullish

Divis Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Divis Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY2,67,167.5818.65%0.522,56810,560
BUY1,76,871.0545.97%0.872,13819,274
HOLD55,898.51-0.32%0.6836816,927
BUY52,125.28-2.81%0.521,0276,430
BUY1,12,851.4510.68%0.523,86939,011

Market expectation of Divis Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

19.23%

Hold

30.77%

Sell

Divis Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
1,855
2,303
2,118
2,338
2,319
2,585
2,410
2,715
2,604
2,831
3,080
Other Income
95
79
79
106
82
86
119
145
88
155
64
Total Income
1,950
2,382
2,197
2,444
2,401
2,671
2,529
2,860
2,692
2,986
3,144
Expenses
1,366
1,572
1,496
1,622
1,576
1,699
1,681
1,827
1,788
1,897
1,825
Operating Profit
489
731
622
716
743
886
729
888
816
934
1,255
Operating Profit Margin %
26.36%
31.74%
29.37%
30.62%
32.04%
34.27%
30.25%
32.71%
31.34%
32.99%
40.75%
Profit Before Interest, Tax and Depreciation
584
810
701
822
825
972
848
1,033
904
1,089
1,319
Interest
-
2
-
1
-
1
3
8
6
6
6
Depreciation
95
95
97
99
99
107
112
113
118
120
133
Profit Before Tax
489
713
604
722
726
864
733
912
780
963
1,180
Tax Paid
131
175
174
212
137
202
188
223
197
212
278
Profit After Tax
358
538
430
510
589
662
545
689
583
751
902
Total Net profit including share of profit / Loss from associate company
358
538
430
510
589
662
545
689
583
751
902
EPS
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
33.95
Actual EPS
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
33.95
Adjusted EPS
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
33.95
Diluted EPS
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
33.95

Divis Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
3,912.78
4,946.26
5,394.42
6,969.4
8,959.83
7,767
7,845
9,360
10,560
Other Income
113.44
155.63
189.63
62.56
113.87
345
339
352
507
Total Income
4,026.22
5,101.89
5,584.05
7,031.96
9,073.7
8,112
8,184
9,712
11,067
Expenses
2,651.07
3,074.42
3,572.25
4,109.46
5,077.89
5,399
5,640
6,392
7,193
Operating Profit
1,261.71
1,871.84
1,822.17
2,859.94
3,881.94
2,368
2,205
2,968
3,367
Operating Profit Margin %
32.25%
37.84%
33.78%
41.04%
43.33%
30.49%
28.11%
31.71%
31.88%
Profit Before Interest, Tax and Depreciation
1,375.15
2,027.47
2,011.8
2,922.5
3,995.81
2,713
2,544
3,320
3,874
Interest
1.33
3.5
6.1
0.87
0.8
1
3
2
23
Depreciation
142.49
168.9
186.24
255.59
311.51
343
378
402
463
Profit Before Tax
1,231.33
1,855.07
1,819.46
2,666.04
3,683.5
2,369
2,163
2,916
3,388
Tax Paid
354.32
502.33
442.92
681.75
723.05
545
563
725
820
Profit After Tax
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
2,568
Total Net profit including share of profit / Loss from associate company
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
2,568
EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Actual EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Adjusted EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Diluted EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75

Divis Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,037.86
1,150.37
775.86
954.3
1,215.94
1,946.93
1,911.8
2,459.73
1,261
1,653
2,738
Cash Flow from Investing Activities
-406.41
-1,139.6
-478.3
-685.4
-83.47
75.13
-2,194.92
-2,707.62
-269
-804
-2,219
Cash Flow from Financing Activities
-631.12
2.38
-314.16
-245.94
-1,091.42
-34.89
-532.44
-797.17
-799
-799
-804
Net Cash Flow
0.33
13.15
-16.6
22.96
41.05
1,987.17
-815.56
-1,045.06
193
50
-285

Divis Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
51.92%
51.92%
51.9%
51.89%
51.89%
51.89%
51.89%
51.89%
51.88%
51.88%
51.88%
51.88%
DII
21.88%
22.21%
21.77%
21.06%
20.54%
20.71%
19.05%
19.76%
19.28%
19.22%
19.38%
19.17%
FII
14.86%
14.68%
16.16%
17.25%
17.99%
18.01%
19.74%
19.39%
20.08%
20.29%
20.2%
20.38%
Public
11.33%
11.19%
10.18%
9.8%
9.59%
9.39%
9.32%
8.96%
8.76%
8.6%
8.54%
8.58%
Total Outstanding Shares
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
Total Shareholders
3,54,482
3,47,629
2,98,310
2,78,899
2,80,601
2,67,755
2,59,825
2,49,634
2,33,844
2,28,006
2,26,324
2,32,256

Mutual Funds Buying / Exiting Divis Laboratories

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Divis Laboratories

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Divis Laboratories

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

SBI Focused Fund Direct Plan Growth

SBI Focused Fund Direct Plan Growth

₹1,304.88 Cr

₹255.61 Cr (-16.38%)

2.41%

SBI Aggressive Hybrid Fund Direct Growth

SBI Aggressive Hybrid Fund Direct Growth

₹1,706.38 Cr

₹189.34 Cr (-9.99%)

1.83%

Axis ELSS - Tax Saver Fund Direct Plan Growth Option

Axis ELSS - Tax Saver Fund Direct Plan Growth Option

₹896.90 Cr

₹40.29 Cr (-4.30%)

2.74%

Divis Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Divis Laboratories.

  • Divis Laboratories Ltd Earnings Results

    Divis Laboratories Ltd’s net profit jumped 65.5% since last year same period to ₹902.00Cr in the Q1 2026-2027. On a quarterly growth basis, Divis Laboratories Ltd has generated 20.11% jump in its net profits since last 3-months.

    Read More
  • Divis Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Divis Laboratories Ltd has declared dividend of ₹30.00 per share on 23 May 2026 - translating a dividend yield of 0.30%.

    Read More about Dividends

Indices Featuring Divis Laboratories Stock

Check stock indices that include Divis Laboratories.

S&P BSE SEN. N50

₹83,820.72

+1,109.32 (▲1.34%)

Nifty Next 50

₹70,795.00

+1,170.65 (▲1.68%)

Nifty100 Quality

₹5,576.40

+8.85 (▲0.16%)

S&P BSE 250 LargeMidCap

₹10,559.14

+105.01 (▲1.00%)

BSE 500

₹35,614.82

+393.81 (▲1.12%)

Nifty 200

₹13,712.65

+130.55 (▲0.96%)

Nifty100 Eq Weig

₹33,729.85

+348.30 (▲1.04%)

Nifty LargeMidcap 250

₹16,159.25

+191.20 (▲1.20%)

Nifty Healthcare

₹16,701.55

+121.15 (▲0.73%)

BSE 100

₹25,443.05

+191.56 (▲0.76%)

NIFTY PHARMA

₹27,333.45

+114.95 (▲0.42%)

S&P BSE Dividend Stability

₹1,019.83

+11.04 (▲1.09%)

BSE Healthcare

₹51,090.89

+514.28 (▲1.02%)

NIFTY 100

₹24,942.35

+202.85 (▲0.82%)

Nifty 500

₹22,769.20

+248.85 (▲1.11%)

BSE MFG

₹1,054.83

+11.02 (▲1.06%)

S&P BSE 100 LargeCap TMC

₹9,004.90

+73.75 (▲0.83%)

S&P BSE 100 ESG

₹404.43

+2.98 (▲0.74%)

BSE 200

₹11,087.50

+110.02 (▲1.00%)

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 20.20% to 20.38% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 583.0 Cr → 902.0 Cr (in ₹), with an average increase of 19.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DIVISLAB stock has moved up by 9.4%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.87% to 14.66% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 8.54% to 8.58% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 2.69K Cr → 3.14K Cr (in ₹), with an average increase of 7.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Laurus Labs Ltd has given 523.8% return, outperforming this stock by 336.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Laurus Labs Ltd has given 136.3% return, outperforming this stock by 88.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.88% of holdings in Sep 2026 quarter

Divis Laboratories Stock Futures & Options Contracts

View the latest movement in Divis Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.

Divis Laboratories Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 23 Nov ₹10000 Call
November 23, 2026
₹10000
₹409.1
23.56
6.11%
DIVISLAB 23 Nov ₹10500 Call
November 23, 2026
₹10500
₹221.65
26.74
13.72%
DIVISLAB 23 Nov ₹11000 Call
November 23, 2026
₹11000
₹111
18.15
19.55%
DIVISLAB 23 Nov ₹11400 Call
November 23, 2026
₹11400
₹61.15
30.25
97.9%

Divis Laboratories Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 23 Nov Fut
November 23, 2026
-
₹10079
20.12
0.2%
DIVISLAB 29 Dec Fut
December 29, 2026
-
₹10124
2.02
0.02%
DIVISLAB 25 Jan Fut
January 25, 2027
-
₹10185
13.22
0.13%

About Divis Laboratories Ltd

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Revenue: ₹3,080.00Cr as on June 2026 (Q1 FY27)
Net Profit: ₹902.00Cr as on June 2026 (Q1 FY27)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORamesh B V Nimmagadda
E-voting on sharesClick here to vote

FAQs

What is Divis Laboratories share price today?

Divis Laboratories share price today stands at ₹10037.5 as on at the close of the market. Divis Laboratories share today touched a day high of ₹10067 and a low of ₹9946.

What is the 52 week high and 52 week low range for Divis Laboratories share?

Divis Laboratories touched a 52 week high of ₹10067 and a 52 week low of ₹5647.5. Divis Laboratories share price today i.e. is closed at ₹10037.5, which is -0.29% down from its 52 week high and 77.73% up from its 52 week low.

What is Divis Laboratories's market capitalisation today?

Divis Laboratories market capitalisation is ₹2,67,167.58 Cr as on .

How to buy Divis Laboratories shares?

To buy Divis Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for DIVISLAB or Divis Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Divis Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Divis Laboratories trading volume today?

Divis Laboratories trading volume is 5.35L as on . This means that 5.35L shares of Divis Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Divis Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest in Divis Laboratories has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 21 days. This reflects platform activity only and is not investment advice.